We have a trio of patent cases for our next installment of The Precedent. The Federal Circuit looked at: The viability of the reverse doctrine of equivalents (RDOE) as a defense to patent infringement. Read more about this decision: https://lnkd.in/giBEajcW Challenges to the validity of a pharmaceutical patent concerning the patent’s written description, enablement and obviousness. Read more about this decision: https://lnkd.in/gbnHCt-P The Patent Trial and Appeal Board’s (PTAB) jurisdiction to conduct IPRs over expired patents under the public-rights doctrine and the proper use of expert witness testimony in IPR determinations of obviousness of patent claims. Read more about this decision: https://lnkd.in/gjMMVaPb
